Dear NMusers,
This is a friendly reminder to *register <https://forms.gle/QnKCqPv8yGnEMvmPA>* for the upcoming *third Educational Pharmacometrics Summer Symposium (EPSS)*, which will be held in-person on 25 June 2024, at the PAGE venue. There are still some places available, so apply before the registration closes (26 May 2024). We hope you can *join us for this free one-day symposium*, which will bring together experts and professionals in the field of pharmacometrics (PMx) to give an overview of what PMx is and how it can contribute to model-informed drug development and therapy individualisation (*programme <https://drive.google.com/file/d/1VeOOIkwmR_co0qtal9fFfJssF6sbPNp4/view>*). The symposium is an excellent opportunity to gain valuable knowledge about PMx, PMx-related career possibilities, and establish professional relationships. Don’t forget that PhD/MSc students are also welcomed to submit PMx-related abstracts for short presentations (accepted PAGE2024 abstracts can be re-used for this purpose). For more information, see below / contact us at epss2...@gmail.com. We look forward to seeing you at the EPSS! Best wishes, EPSS 2024 organisers: Eva Germovsek (Boehringer Ingelheim), Jurij Aguiar Zdovc (Pharmetheus), Ludovica Aiello (University of Pavia) On Mon, Mar 25, 2024 at 3:35 PM 3rd Educational Pharmacometrics Summer Symposium <epss2...@gmail.com> wrote: > Dear NMusers, > > We are pleased to invite you to the upcoming third Educational > Pharmacometrics Summer Symposium (EPSS), which will be held on 25 June > 2024, at the PAGE venue. This one-day symposium will bring together > experts and professionals in the field of pharmacometrics (PMx) to give an > overview of what PMx is and how it can contribute to model-informed drug > development and therapy individualisation (programme > <https://drive.google.com/file/d/1VeOOIkwmR_co0qtal9fFfJssF6sbPNp4/view>). > > In short, the symposium will begin with a brief introduction to PMx, > followed by a discussion on the use of PMx to optimise and personalise > treatment. After lunch and networking, the use of PMx in drug development, > covering preclinical and clinical applications, will be presented, followed > by PMx case studies, which will be based on submitted student abstracts. > The symposium will conclude with a short group work session. With speakers > from academia, pharmaceutical industry and consultancy, this event covers a > broad range of PMx roles and may also be a great opportunity for those > looking for the next step in their career development. > > The symposium is intended for students from all natural sciences (Master > and PhD), postdocs, and others with an interest in pharmacometrics, such > as, clinical pharmacists, clinicians, mathematicians, statisticians, or > colleagues from industry. > > Students or postdocs/trainees may apply to present their original > PMx-related work as a part of the symposium (submitted abstract should > not exceed 4,500 characters, including spaces, and may be the same as for > the PAGE meeting); abstract submission deadline is 26 May 2024. The > participation is free of charge. Light lunch will be provided. To > register please follow this link <https://forms.gle/QnKCqPv8yGnEMvmPA> > (open until 26 May 2024). Based on last years’ positive feedback, > register early to avoid missing out. For more information, please do not > hesitate to contact us at epss2...@gmail.com. > > Best wishes, > > EPSS 2024 organisers: > > Eva Germovsek (Boehringer Ingelheim), > > Jurij Aguiar Zdovc (Pharmetheus), > > Ludovica Aiello (University of Pavia) >
